◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT04933370 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Alberta Health Services, Calgary |
| Condition | Chronic Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2022-02-01 |
| Primary Completion | 2026-07-01 |
Trial Parameters
Condition Chronic Pain
Sponsor Alberta Health Services, Calgary
Study Type INTERVENTIONAL
Phase N/A
Enrollment 20
Sex ALL
Min Age 18 Years
Max Age 100 Years
Start Date 2022-02-01
Completion 2026-07-01
Interventions
Stimulation parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The objective of this study is to determine the efficacy of neuromodulation using various stimulation paradigms in the treatment of several disorders including chronic pain.
Eligibility Criteria
Inclusion Criteria: * Patients who are candidates for, and have been consented for, implantation of a neuromodulation device. Exclusion Criteria: * Non-English speaking
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology